195 related articles for article (PubMed ID: 25744017)
21. Pulse Wave Velocity Predicts Response to Renal Denervation in Isolated Systolic Hypertension.
Fengler K; Rommel KP; Hoellriegel R; Blazek S; Besler C; Desch S; Schuler G; Linke A; Lurz P
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515119
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience.
Fengler K; Höllriegel R; Okon T; Stiermaier T; Rommel KP; Blazek S; Besler C; von Roeder M; Petzold M; Schuler G; Lurz P
J Hypertens; 2017 Jun; 35(6):1310-1317. PubMed ID: 28441700
[TBL] [Abstract][Full Text] [Related]
23. Impact of sympathetic renal denervation: a randomized study in patients after renal transplantation (ISAR-denerve).
Schneider S; Promny D; Sinnecker D; Byrne RA; Müller A; Dommasch M; Wildenauer A; Schmidt G; Heemann U; Laugwitz KL; Baumann M
Nephrol Dial Transplant; 2015 Nov; 30(11):1928-36. PubMed ID: 26333545
[TBL] [Abstract][Full Text] [Related]
24. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
Ewen S; Dörr O; Ukena C; Linz D; Cremers B; Laufs U; Hamm C; Nef H; Bauer A; Mancia G; Böhm M; Mahfoud F
J Hypertens; 2015 Dec; 33(12):2512-8. PubMed ID: 26485461
[TBL] [Abstract][Full Text] [Related]
25. RADIANCE-HTN TRIO: how the saga of renal denervation revisits hypertension therapy.
Tsioufis KP; Dimitriadis K
Cardiovasc Res; 2021 Sep; 117(11):e141-e143. PubMed ID: 34562002
[No Abstract] [Full Text] [Related]
26. Efficacy and safety of renal denervation in elderly patients with resistant hypertension.
Ziegler AK; Bertog S; Kaltenbach B; Id D; Franke J; Hofmann I; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2015 Aug; 86(2):299-303. PubMed ID: 23983010
[TBL] [Abstract][Full Text] [Related]
27. SPYRAL HTN-OFF MED study: Renal denervation in the spiral orbits of current results and future studies.
Tsioufis C; Dimitriadis K; Papademetriou V; Tousoulis D
Hellenic J Cardiol; 2017; 58(5):320-321. PubMed ID: 29056558
[No Abstract] [Full Text] [Related]
28. Limitations in current clinical trials on renal denervation.
Wang Y
Int J Cardiol; 2014 Jun; 174(1):225. PubMed ID: 24767754
[No Abstract] [Full Text] [Related]
29. Renal sympathetic denervation and daily life blood pressure in resistant hypertension: simplicity or complexity?
Parati G; Ochoa JE; Bilo G
Circulation; 2013 Jul; 128(4):315-7. PubMed ID: 23780577
[No Abstract] [Full Text] [Related]
30. Chemical Renal Denervation: The Pursuit for Simplicity.
Waksman R
JACC Cardiovasc Interv; 2016 Mar; 9(6):599-601. PubMed ID: 27013160
[No Abstract] [Full Text] [Related]
31. Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance.
Ewen S; Cremers B; Meyer MR; Donazzan L; Kindermann I; Ukena C; Helfer AG; Maurer HH; Laufs U; Grassi G; Böhm M; Mahfoud F
J Hypertens; 2015 Dec; 33(12):2519-25. PubMed ID: 26485463
[TBL] [Abstract][Full Text] [Related]
32. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ
Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672
[TBL] [Abstract][Full Text] [Related]
33. The setback of renal denervation should not backfire on sympathetic overactivity in hypertension.
Kjeldsen SE; Fadl Elmula FEM; Persu A
J Am Coll Cardiol; 2015 Apr; 65(13):1322-1323. PubMed ID: 25835444
[No Abstract] [Full Text] [Related]
34. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
Khan NA; Herman RJ; Quinn RR; Rabkin SW; Ravani P; Tobe SW; Feldman RD; Wijeysundera HC; Padwal RS;
Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
[TBL] [Abstract][Full Text] [Related]
35. Are we on the path to solve the enigma of resistant hypertension: renal sympathetic denervation.
Gerc V; Buksa M
Med Arch; 2013 Dec; 67(6):454-9. PubMed ID: 25568521
[TBL] [Abstract][Full Text] [Related]
36. Vascular response after percutaneous sympathectomy: not all devices are equal.
Versaci F; Trivisonno A; Olivieri C; Caranci F; Brunese L; Prati F
Int J Cardiol; 2014 Jun; 174(2):406-7. PubMed ID: 24768375
[No Abstract] [Full Text] [Related]
37. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
[TBL] [Abstract][Full Text] [Related]
38. Effect of unilateral catheter-based renal sympathetic denervation in a patient with resistant hypertension.
Kostka-Jeziorny K; Radziemski A; Tykarski A; Niklas A; Grajek S
Kardiol Pol; 2015; 73(2):132. PubMed ID: 25706782
[No Abstract] [Full Text] [Related]
39. Denervation of the distal renal arterial branches vs. conventional main renal artery treatment: a randomized controlled trial for treatment of resistant hypertension.
Pekarskiy SE; Baev AE; Mordovin VF; Semke GV; Ripp TM; Falkovskaya AU; Lichikaki VA; Sitkova ES; Zubanova IV; Popov SV
J Hypertens; 2017 Feb; 35(2):369-375. PubMed ID: 28005705
[TBL] [Abstract][Full Text] [Related]
40. Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial.
Yerasi C; Baker NC; Jonnalagadda AK; Torguson R; Singh S; Vies J; Waksman R
J Am Soc Hypertens; 2015 Dec; 9(12):959-65. PubMed ID: 26687550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
